Global Nasal Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 30-Nov-2022
No. of pages: 114
Inquire Before Buying

Report Scope

This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Nasal Vaccines manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Nasal Vaccines market. Further, it explains the major drivers and regional dynamics of the global Nasal Vaccines market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- Sanofi

- AstraZeneca

- Abbott

- GlaxoSmithKline

- Serum Institute of India

- Bharat Biotech

- Antares Pharma

- INJEX Pharma GmbH

- BioDiem

- PharmaJet and Crossject

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.

Nasal Vaccines Segment by Type

- Flu Vaccines

- COVID-19 Vaccines

- Other Vaccines

Nasal Vaccines Segment by Application

- Adult

- Children

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- - Colombia

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Nasal Vaccines market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Nasal Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Nasal Vaccines, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Nasal Vaccines, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Nasal Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Nasal Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Nasal Vaccines sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Sanofi, AstraZeneca, Abbott, GlaxoSmithKline, Serum Institute of India, Bharat Biotech, Antares Pharma, INJEX Pharma GmbH and BioDiem, etc.

Global Nasal Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Nasal Vaccines Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Flu Vaccines
1.2.3 COVID-19 Vaccines
1.2.4 Other Vaccines
1.3 Market Segment by Application
1.3.1 Global Nasal Vaccines Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Adult
1.3.3 Children
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Nasal Vaccines Market Size (2017-2028)
2.1.1 Global Nasal Vaccines Revenue (2017-2028)
2.1.2 Global Nasal Vaccines Sales (2017-2028)
2.2 Global Nasal Vaccines Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Nasal Vaccines Sales by Regions (2017-2022)
2.2.2 Global Nasal Vaccines Revenue by Regions (2017-2022)
2.3 Global Nasal Vaccines Market Size Forecast by Region
2.3.1 Global Nasal Vaccines Sales Forecast by Region (2023-2028)
2.3.2 Global Nasal Vaccines Revenue Forecast by Region (2023-2028)
2.4 Global Top Nasal Vaccines Regions (Countries) Ranking by Market Size
2.5 Nasal Vaccines Market Dynamics
2.5.1 Nasal Vaccines Market Trends
2.5.2 Nasal Vaccines Market Drivers
2.5.3 Nasal Vaccines Market Challenges
2.5.4 Nasal Vaccines Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Nasal Vaccines Manufacturers by Sales (2017-2022)
3.1.1 Global Nasal Vaccines Sales by Manufacturers (2017-2022)
3.1.2 Global Nasal Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Nasal Vaccines Sales in 2021
3.2 Global Top Manufacturers Nasal Vaccines by Revenue
3.2.1 Global Nasal Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Top Nasal Vaccines Manufacturers Covered: Ranking by Revenue
3.2.3 Global Nasal Vaccines Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Nasal Vaccines Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nasal Vaccines as of 2021)
3.4 Global Nasal Vaccines Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Nasal Vaccines Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Nasal Vaccines Market
3.7 Key Manufacturers Nasal Vaccines Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Nasal Vaccines Market Size by Type
4.1 Global Nasal Vaccines Historic Market Review by Type (2017-2022)
4.1.1 Global Nasal Vaccines Sales Market Share by Type (2017-2022)
4.1.2 Global Nasal Vaccines Revenue Market Share by Type (2017-2022)
4.1.3 Nasal Vaccines Price by Type (2017-2022)
4.2 Global Nasal Vaccines Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Nasal Vaccines Sales Forecast by Type (2023-2028)
4.2.2 Global Nasal Vaccines Revenue Forecast by Type (2023-2028)
4.2.3 Nasal Vaccines Price Forecast by Type (2023-2028)
5 Global Nasal Vaccines Market Size by Application
5.1 Global Nasal Vaccines Historic Market Review by Application (2017-2022)
5.1.1 Global Nasal Vaccines Sales Market Share by Application (2017-2022)
5.1.2 Global Nasal Vaccines Revenue Market Share by Application (2017-2022)
5.1.3 Nasal Vaccines Price by Application (2017-2022)
5.2 Global Nasal Vaccines Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Nasal Vaccines Sales Forecast by Application (2023-2028)
5.2.2 Global Nasal Vaccines Revenue Forecast by Application (2023-2028)
5.2.3 Nasal Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America Nasal Vaccines Sales Breakdown by Company
6.1.1 North America Nasal Vaccines Sales by Company (2017-2022)
6.1.2 North America Nasal Vaccines Revenue by Company (2017-2022)
6.2 North America Nasal Vaccines Market Size by Type
6.2.1 North America Nasal Vaccines Sales by Type (2017-2028)
6.2.2 North America Nasal Vaccines Revenue by Type (2017-2028)
6.3 North America Nasal Vaccines Market Size by Application
6.3.1 North America Nasal Vaccines Sales by Application (2017-2028)
6.3.2 North America Nasal Vaccines Revenue by Application (2017-2028)
6.4 North America Nasal Vaccines Market Size by Country
6.4.1 North America Nasal Vaccines Sales by Country (2017-2028)
6.4.2 North America Nasal Vaccines Revenue by Country (2017-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Nasal Vaccines Sales Breakdown by Company
7.1.1 Europe Nasal Vaccines Sales by Company (2017-2022)
7.1.2 Europe Nasal Vaccines Revenue by Company (2017-2022)
7.2 Europe Nasal Vaccines Market Size by Type
7.2.1 Europe Nasal Vaccines Sales by Type (2017-2028)
7.2.2 Europe Nasal Vaccines Revenue by Type (2017-2028)
7.3 Europe Nasal Vaccines Market Size by Application
7.3.1 Europe Nasal Vaccines Sales by Application (2017-2028)
7.3.2 Europe Nasal Vaccines Revenue by Application (2017-2028)
7.4 Europe Nasal Vaccines Market Size by Country
7.4.1 Europe Nasal Vaccines Sales by Country (2017-2028)
7.4.2 Europe Nasal Vaccines Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Nasal Vaccines Sales Breakdown by Company
8.1.1 Asia Pacific Nasal Vaccines Sales by Company (2017-2022)
8.1.2 Asia Pacific Nasal Vaccines Revenue by Company (2017-2022)
8.2 Asia Pacific Nasal Vaccines Market Size by Type
8.2.1 Asia Pacific Nasal Vaccines Sales by Type (2017-2028)
8.2.2 Asia Pacific Nasal Vaccines Revenue by Type (2017-2028)
8.3 Asia Pacific Nasal Vaccines Market Size by Application
8.3.1 Asia Pacific Nasal Vaccines Sales by Application (2017-2028)
8.3.2 Asia Pacific Nasal Vaccines Revenue by Application (2017-2028)
8.4 Asia Pacific Nasal Vaccines Market Size by Region
8.4.1 Asia Pacific Nasal Vaccines Sales by Region
8.4.2 Asia Pacific Nasal Vaccines Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 China Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
9 Latin America
9.1 Latin America Nasal Vaccines Sales Breakdown by Company
9.1.1 Latin America Nasal Vaccines Sales by Company (2017-2022)
9.1.2 Latin America Nasal Vaccines Revenue by Company (2017-2022)
9.2 Latin America Nasal Vaccines Market Size by Type
9.2.1 Latin America Nasal Vaccines Sales by Type (2017-2028)
9.2.2 Latin America Nasal Vaccines Revenue by Type (2017-2028)
9.3 Latin America Nasal Vaccines Market Size by Application
9.3.1 Latin America Nasal Vaccines Sales by Application (2017-2028)
9.3.2 Latin America Nasal Vaccines Revenue by Application (2017-2028)
9.4 Latin America Nasal Vaccines Market Size by Country
9.4.1 Latin America Nasal Vaccines Sales by Country (2017-2028)
9.4.2 Latin America Nasal Vaccines Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
9.4.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Nasal Vaccines Sales Breakdown by Company
10.1.1 Middle East and Africa Nasal Vaccines Sales by Company (2017-2022)
10.1.2 Middle East and Africa Nasal Vaccines Revenue by Company (2017-2022)
10.2 Middle East and Africa Nasal Vaccines Market Size by Type
10.2.1 Middle East and Africa Nasal Vaccines Sales by Type (2017-2028)
10.2.2 Middle East and Africa Nasal Vaccines Revenue by Type (2017-2028)
10.3 Middle East and Africa Nasal Vaccines Market Size by Application
10.3.1 Middle East and Africa Nasal Vaccines Sales by Application (2017-2028)
10.3.2 Middle East and Africa Nasal Vaccines Revenue by Application (2017-2028)
10.4 Middle East and Africa Nasal Vaccines Market Size by Country
10.4.1 Middle East and Africa Nasal Vaccines Sales by Country (2017-2028)
10.4.2 Middle East and Africa Nasal Vaccines Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Nasal Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Sanofi Nasal Vaccines Products and Services
11.1.5 Sanofi Nasal Vaccines SWOT Analysis
11.1.6 Sanofi Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Corporation Information
11.2.2 AstraZeneca Overview
11.2.3 AstraZeneca Nasal Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 AstraZeneca Nasal Vaccines Products and Services
11.2.5 AstraZeneca Nasal Vaccines SWOT Analysis
11.2.6 AstraZeneca Recent Developments
11.3 Abbott
11.3.1 Abbott Corporation Information
11.3.2 Abbott Overview
11.3.3 Abbott Nasal Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Abbott Nasal Vaccines Products and Services
11.3.5 Abbott Nasal Vaccines SWOT Analysis
11.3.6 Abbott Recent Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Corporation Information
11.4.2 GlaxoSmithKline Overview
11.4.3 GlaxoSmithKline Nasal Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 GlaxoSmithKline Nasal Vaccines Products and Services
11.4.5 GlaxoSmithKline Nasal Vaccines SWOT Analysis
11.4.6 GlaxoSmithKline Recent Developments
11.5 Serum Institute of India
11.5.1 Serum Institute of India Corporation Information
11.5.2 Serum Institute of India Overview
11.5.3 Serum Institute of India Nasal Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Serum Institute of India Nasal Vaccines Products and Services
11.5.5 Serum Institute of India Nasal Vaccines SWOT Analysis
11.5.6 Serum Institute of India Recent Developments
11.6 Bharat Biotech
11.6.1 Bharat Biotech Corporation Information
11.6.2 Bharat Biotech Overview
11.6.3 Bharat Biotech Nasal Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Bharat Biotech Nasal Vaccines Products and Services
11.6.5 Bharat Biotech Nasal Vaccines SWOT Analysis
11.6.6 Bharat Biotech Recent Developments
11.7 Antares Pharma
11.7.1 Antares Pharma Corporation Information
11.7.2 Antares Pharma Overview
11.7.3 Antares Pharma Nasal Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Antares Pharma Nasal Vaccines Products and Services
11.7.5 Antares Pharma Nasal Vaccines SWOT Analysis
11.7.6 Antares Pharma Recent Developments
11.8 INJEX Pharma GmbH
11.8.1 INJEX Pharma GmbH Corporation Information
11.8.2 INJEX Pharma GmbH Overview
11.8.3 INJEX Pharma GmbH Nasal Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 INJEX Pharma GmbH Nasal Vaccines Products and Services
11.8.5 INJEX Pharma GmbH Nasal Vaccines SWOT Analysis
11.8.6 INJEX Pharma GmbH Recent Developments
11.9 BioDiem
11.9.1 BioDiem Corporation Information
11.9.2 BioDiem Overview
11.9.3 BioDiem Nasal Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 BioDiem Nasal Vaccines Products and Services
11.9.5 BioDiem Nasal Vaccines SWOT Analysis
11.9.6 BioDiem Recent Developments
11.10 PharmaJet and Crossject
11.10.1 PharmaJet and Crossject Corporation Information
11.10.2 PharmaJet and Crossject Overview
11.10.3 PharmaJet and Crossject Nasal Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.10.4 PharmaJet and Crossject Nasal Vaccines Products and Services
11.10.5 PharmaJet and Crossject Nasal Vaccines SWOT Analysis
11.10.6 PharmaJet and Crossject Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Nasal Vaccines Value Chain Analysis
12.2 Nasal Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Nasal Vaccines Production Mode & Process
12.4 Nasal Vaccines Sales and Marketing
12.4.1 Nasal Vaccines Sales Channels
12.4.2 Nasal Vaccines Distributors
12.5 Nasal Vaccines Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Nasal Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Flu Vaccines
Table 3. Major Manufacturers of COVID-19 Vaccines
Table 4. Major Manufacturers of Other Vaccines
Table 5. Global Nasal Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Nasal Vaccines Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 7. Global Nasal Vaccines Sales by Region (2017-2022) & (K Dose)
Table 8. Global Nasal Vaccines Sales Market Share by Region (2017-2022)
Table 9. Global Nasal Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 10. Global Nasal Vaccines Revenue Market Share by Region (2017-2022)
Table 11. Global Nasal Vaccines Sales Forecast by Region (2023-2028) & (K Dose)
Table 12. Global Nasal Vaccines Sales Market Share Forecast by Region (2023-2028)
Table 13. Global Nasal Vaccines Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 14. Global Nasal Vaccines Revenue Market Share Forecast by Region (2023-2028)
Table 15. Top Nasal Vaccines Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 16. Nasal Vaccines Market Trends
Table 17. Nasal Vaccines Market Drivers
Table 18. Nasal Vaccines Market Challenges
Table 19. Nasal Vaccines Market Restraints
Table 20. Global Nasal Vaccines Sales by Manufacturers (2017-2022) & (K Dose)
Table 21. Global Nasal Vaccines Sales Share by Manufacturers (2017-2022)
Table 22. Global Nasal Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 23. Ranking of Global Top Nasal Vaccines Manufacturers by Revenue (US$ Million) in 2021
Table 24. Nasal Vaccines Revenue Share by Manufacturers (2017-2022)
Table 25. Global Nasal Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nasal Vaccines as of 2021)
Table 27. Key Manufacturers Nasal Vaccines Average Selling Price (ASP) & (2017-2022) & (US$/Dose)
Table 28. Key Manufacturers Nasal Vaccines Plants/Factories Distribution
Table 29. Key Manufacturers Nasal Vaccines Area Served
Table 30. Date of Key Manufacturers Enter into Nasal Vaccines Market
Table 31. Key Manufacturers Nasal Vaccines Product Type
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Nasal Vaccines Sales (K Dose) by Type (2017-2022)
Table 34. Global Nasal Vaccines Sales Share by Type (2017-2022)
Table 35. Global Nasal Vaccines Revenue (US$ Million) Market Share by Type (2017-2022)
Table 36. Global Nasal Vaccines Price (K Dose) by Type (2017-2022)
Table 37. Global Nasal Vaccines Sales (K Dose) by Type (2023-2028)
Table 38. Global Nasal Vaccines Sales Share by Type (2023-2028)
Table 39. Global Nasal Vaccines Revenue (US$ Million) Market Share by Type (2023-2028)
Table 40. Global Nasal Vaccines Revenue Share by Type (2023-2028)
Table 41. Global Nasal Vaccines Price (K Dose) by Type (2023-2028)
Table 42. Global Nasal Vaccines Sales (K Dose) by Application (2017-2022)
Table 43. Global Nasal Vaccines Sales Share by Application (2017-2022)
Table 44. Global Nasal Vaccines Revenue (US$ Million) Market Share by Application (2017-2022)
Table 45. Global Nasal Vaccines Price (K Dose) by Application (2017-2022)
Table 46. Global Nasal Vaccines Sales (K Dose) by Application (2023-2028)
Table 47. Global Nasal Vaccines Sales Share by Application (2023-2028)
Table 48. Global Nasal Vaccines Revenue (US$ Million) Market Share by Application (2023-2028)
Table 49. Global Nasal Vaccines Revenue Share by Application (2023-2028)
Table 50. Global Nasal Vaccines Price (K Dose) by Application (2023-2028)
Table 51. North America Nasal Vaccines Sales by Company (2017-2022) & (K Dose)
Table 52. North America Nasal Vaccines Sales Market Share by Company (2017-2022)
Table 53. North America Nasal Vaccines Revenue by Company (2017-2022) & (US$ Million)
Table 54. North America Nasal Vaccines Revenue Market Share by Company (2017-2022)
Table 55. North America Nasal Vaccines Sales by Type (2017-2022) & (K Dose)
Table 56. North America Nasal Vaccines Sales by Type (2023-2028) & (K Dose)
Table 57. North America Nasal Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 58. North America Nasal Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 59. North America Nasal Vaccines Sales by Application (2017-2022) & (K Dose)
Table 60. North America Nasal Vaccines Sales by Application (2023-2028) & (K Dose)
Table 61. North America Nasal Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 62. North America Nasal Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 63. North America Nasal Vaccines Sales by Country (2017-2022) & (K Dose)
Table 64. North America Nasal Vaccines Sales by Country (2023-2028) & (K Dose)
Table 65. North America Nasal Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 66. North America Nasal Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 67. Europe Nasal Vaccines Sales by Company (2017-2022) & (K Dose)
Table 68. Europe Nasal Vaccines Sales Market Share by Company (2017-2022)
Table 69. Europe Nasal Vaccines Revenue by Company (2017-2022) & (US$ Million)
Table 70. Europe Nasal Vaccines Revenue Market Share by Company (2017-2022)
Table 71. Europe Nasal Vaccines Sales by Type (2017-2022) & (K Dose)
Table 72. Europe Nasal Vaccines Sales by Type (2023-2028) & (K Dose)
Table 73. Europe Nasal Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 74. Europe Nasal Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 75. Europe Nasal Vaccines Sales by Application (2017-2022) & (K Dose)
Table 76. Europe Nasal Vaccines Sales by Application (2023-2028) & (K Dose)
Table 77. Europe Nasal Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 78. Europe Nasal Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 79. Europe Nasal Vaccines Sales by Country (2017-2022) & (K Dose)
Table 80. Europe Nasal Vaccines Sales by Country (2023-2028) & (K Dose)
Table 81. Europe Nasal Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 82. Europe Nasal Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 83. Asia Pacific Nasal Vaccines Sales by Company (2017-2022) & (K Dose)
Table 84. Asia Pacific Nasal Vaccines Sales Market Share by Company (2017-2022)
Table 85. Asia Pacific Nasal Vaccines Revenue by Company (2017-2022) & (US$ Million)
Table 86. Asia Pacific Nasal Vaccines Revenue Market Share by Company (2017-2022)
Table 87. Asia Pacific Nasal Vaccines Sales by Type (2017-2022) & (K Dose)
Table 88. Asia Pacific Nasal Vaccines Sales by Type (2023-2028) & (K Dose)
Table 89. Asia Pacific Nasal Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 90. Asia Pacific Nasal Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 91. Asia Pacific Nasal Vaccines Sales by Application (2017-2022) & (K Dose)
Table 92. Asia Pacific Nasal Vaccines Sales by Application (2023-2028) & (K Dose)
Table 93. Asia Pacific Nasal Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 94. Asia Pacific Nasal Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 95. Asia Pacific Nasal Vaccines Sales by Region (2017-2022) & (K Dose)
Table 96. Asia Pacific Nasal Vaccines Sales by Region (2023-2028) & (K Dose)
Table 97. Asia Pacific Nasal Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 98. Asia Pacific Nasal Vaccines Revenue by Region (2023-2028) & (US$ Million)
Table 99. Latin America Nasal Vaccines Sales by Company (2017-2022) & (K Dose)
Table 100. Latin America Nasal Vaccines Sales Market Share by Company (2017-2022)
Table 101. Latin America Nasal Vaccines Revenue by Company (2017-2022) & (US$ Million)
Table 102. Latin America Nasal Vaccines Revenue Market Share by Company (2017-2022)
Table 103. Latin America Nasal Vaccines Sales by Type (2017-2022) & (K Dose)
Table 104. Latin America Nasal Vaccines Sales by Type (2023-2028) & (K Dose)
Table 105. Latin America Nasal Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 106. Latin America Nasal Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 107. Latin America Nasal Vaccines Sales by Application (2017-2022) & (K Dose)
Table 108. Latin America Nasal Vaccines Sales by Application (2023-2028) & (K Dose)
Table 109. Latin America Nasal Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 110. Latin America Nasal Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 111. Latin America Nasal Vaccines Sales by Country (2017-2022) & (K Dose)
Table 112. Latin America Nasal Vaccines Sales by Country (2023-2028) & (K Dose)
Table 113. Latin America Nasal Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 114. Latin America Nasal Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 115. Middle East and Africa Nasal Vaccines Sales by Company (2017-2022) & (K Dose)
Table 116. Middle East and Africa Nasal Vaccines Sales Market Share by Company (2017-2022)
Table 117. Middle East and Africa Nasal Vaccines Revenue by Company (2017-2022) & (US$ Million)
Table 118. Middle East and Africa Nasal Vaccines Revenue Market Share by Company (2017-2022)
Table 119. Middle East and Africa Nasal Vaccines Sales by Type (2017-2022) & (K Dose)
Table 120. Middle East and Africa Nasal Vaccines Sales by Type (2023-2028) & (K Dose)
Table 121. Middle East and Africa Nasal Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 122. Middle East and Africa Nasal Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 123. Middle East and Africa Nasal Vaccines Sales by Application (2017-2022) & (K Dose)
Table 124. Middle East and Africa Nasal Vaccines Sales by Application (2023-2028) & (K Dose)
Table 125. Middle East and Africa Nasal Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 126. Middle East and Africa Nasal Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 127. Middle East and Africa Nasal Vaccines Sales by Country (2017-2022) & (K Dose)
Table 128. Middle East and Africa Nasal Vaccines Sales by Country (2023-2028) & (K Dose)
Table 129. Middle East and Africa Nasal Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 130. Middle East and Africa Nasal Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 131. Sanofi Corporation Information
Table 132. Sanofi Description and Overview
Table 133. Sanofi Nasal Vaccines Sales (K Dose), Revenue (US$ Million), Average Selling Price (ASP) (US$/Dose) and Gross Margin (2017-2022)
Table 134. Sanofi Nasal Vaccines Product and Services
Table 135. Sanofi Nasal Vaccines SWOT Analysis
Table 136. Sanofi Recent Developments
Table 137. AstraZeneca Corporation Information
Table 138. AstraZeneca Description and Overview
Table 139. AstraZeneca Nasal Vaccines Sales (K Dose), Revenue (US$ Million), Average Selling Price (ASP) (US$/Dose) and Gross Margin (2017-2022)
Table 140. AstraZeneca Nasal Vaccines Product and Services
Table 141. AstraZeneca Nasal Vaccines SWOT Analysis
Table 142. AstraZeneca Recent Developments
Table 143. Abbott Corporation Information
Table 144. Abbott Description and Overview
Table 145. Abbott Nasal Vaccines Sales (K Dose), Revenue (US$ Million), Average Selling Price (ASP) (US$/Dose) and Gross Margin (2017-2022)
Table 146. Abbott Nasal Vaccines Product and Services
Table 147. Abbott Nasal Vaccines SWOT Analysis
Table 148. Abbott Recent Developments
Table 149. GlaxoSmithKline Corporation Information
Table 150. GlaxoSmithKline Description and Overview
Table 151. GlaxoSmithKline Nasal Vaccines Sales (K Dose), Revenue (US$ Million), Average Selling Price (ASP) (US$/Dose) and Gross Margin (2017-2022)
Table 152. GlaxoSmithKline Nasal Vaccines Product and Services
Table 153. GlaxoSmithKline Nasal Vaccines SWOT Analysis
Table 154. GlaxoSmithKline Recent Developments
Table 155. Serum Institute of India Corporation Information
Table 156. Serum Institute of India Description and Overview
Table 157. Serum Institute of India Nasal Vaccines Sales (K Dose), Revenue (US$ Million), Average Selling Price (ASP) (US$/Dose) and Gross Margin (2017-2022)
Table 158. Serum Institute of India Nasal Vaccines Product and Services
Table 159. Serum Institute of India Nasal Vaccines SWOT Analysis
Table 160. Serum Institute of India Recent Developments
Table 161. Bharat Biotech Corporation Information
Table 162. Bharat Biotech Description and Overview
Table 163. Bharat Biotech Nasal Vaccines Sales (K Dose), Revenue (US$ Million), Average Selling Price (ASP) (US$/Dose) and Gross Margin (2017-2022)
Table 164. Bharat Biotech Nasal Vaccines Product and Services
Table 165. Bharat Biotech Nasal Vaccines SWOT Analysis
Table 166. Bharat Biotech Recent Developments
Table 167. Antares Pharma Corporation Information
Table 168. Antares Pharma Description and Overview
Table 169. Antares Pharma Nasal Vaccines Sales (K Dose), Revenue (US$ Million), Average Selling Price (ASP) (US$/Dose) and Gross Margin (2017-2022)
Table 170. Antares Pharma Nasal Vaccines Product and Services
Table 171. Antares Pharma Nasal Vaccines SWOT Analysis
Table 172. Antares Pharma Recent Developments
Table 173. INJEX Pharma GmbH Corporation Information
Table 174. INJEX Pharma GmbH Description and Overview
Table 175. INJEX Pharma GmbH Nasal Vaccines Sales (K Dose), Revenue (US$ Million), Average Selling Price (ASP) (US$/Dose) and Gross Margin (2017-2022)
Table 176. INJEX Pharma GmbH Nasal Vaccines Product and Services
Table 177. INJEX Pharma GmbH Nasal Vaccines SWOT Analysis
Table 178. INJEX Pharma GmbH Recent Developments
Table 179. BioDiem Corporation Information
Table 180. BioDiem Description and Overview
Table 181. BioDiem Nasal Vaccines Sales (K Dose), Revenue (US$ Million), Average Selling Price (ASP) (US$/Dose) and Gross Margin (2017-2022)
Table 182. BioDiem Nasal Vaccines Product and Services
Table 183. BioDiem Nasal Vaccines SWOT Analysis
Table 184. BioDiem Recent Developments
Table 185. PharmaJet and Crossject Corporation Information
Table 186. PharmaJet and Crossject Description and Overview
Table 187. PharmaJet and Crossject Nasal Vaccines Sales (K Dose), Revenue (US$ Million), Average Selling Price (ASP) (US$/Dose) and Gross Margin (2017-2022)
Table 188. PharmaJet and Crossject Nasal Vaccines Product and Services
Table 189. PharmaJet and Crossject Nasal Vaccines SWOT Analysis
Table 190. PharmaJet and Crossject Recent Developments
Table 191. Key Raw Materials Lists
Table 192. Raw Materials Key Suppliers Lists
Table 193. Nasal Vaccines Distributors List
Table 194. Nasal Vaccines Customers List
Table 195. Research Programs/Design for This Report
Table 196. Key Data Information from Secondary Sources
Table 197. Key Data Information from Primary Sources
List of Figures
Figure 1. Nasal Vaccines Product Picture
Figure 2. Global Nasal Vaccines Sales Market Share by Type in 2021 & 2028
Figure 3. Flu Vaccines Product Picture
Figure 4. COVID-19 Vaccines Product Picture
Figure 5. Other Vaccines Product Picture
Figure 6. Global Nasal Vaccines Sales Market Share by Application in 2021 & 2028
Figure 7. Adult Use Case
Figure 8. Children Use Case
Figure 9. Nasal Vaccines Report Years Considered
Figure 10. Global Nasal Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Nasal Vaccines Market Size 2017-2028 (US$ Million)
Figure 12. Global Nasal Vaccines Sales (2017-2022) & (K Dose)
Figure 13. Global Nasal Vaccines Market Size Market Share by Region: 2021 VS 2028
Figure 14. Global Nasal Vaccines Sales Market Share by Region (2017-2022)
Figure 15. Global Nasal Vaccines Sales Market Share by Region in 2021
Figure 16. Global Nasal Vaccines Revenue Market Share by Region in 2017 VS 2021
Figure 17. Global Nasal Vaccines Sales Share by Manufacturers in 2021
Figure 18. The 5 and 10 Largest Manufacturers in the World: Market Share by Nasal Vaccines Sales in 2021
Figure 19. Nasal Vaccines Revenue Share by Manufacturers in 2021
Figure 20. Nasal Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 21. Global Nasal Vaccines Revenue Share by Type (2017-2022)
Figure 22. Global Nasal Vaccines Revenue Growth Rate by Type in 2017 & 2021
Figure 23. Global Nasal Vaccines Revenue Share by Application (2017-2022)
Figure 24. Global Nasal Vaccines Revenue Growth Rate by Application in 2017 & 2021
Figure 25. North America Nasal Vaccines Sales Market Share by Type (2017-2028)
Figure 26. North America Nasal Vaccines Revenue Market Share by Type (2017-2028)
Figure 27. North America Nasal Vaccines Sales Market Share by Application (2017-2028)
Figure 28. North America Nasal Vaccines Revenue Market Share by Application (2017-2028)
Figure 29. North America Nasal Vaccines Sales Share by Country (2017-2028)
Figure 30. North America Nasal Vaccines Revenue Share by Country (2017-2028)
Figure 31. United States Nasal Vaccines Revenue (2017-2028) & (US$ Million)
Figure 32. Canada Nasal Vaccines Revenue (2017-2028) & (US$ Million)
Figure 33. Europe Nasal Vaccines Sales Market Share by Type (2017-2028)
Figure 34. Europe Nasal Vaccines Revenue Market Share by Type (2017-2028)
Figure 35. Europe Nasal Vaccines Sales Market Share by Application (2017-2028)
Figure 36. Europe Nasal Vaccines Revenue Market Share by Application (2017-2028)
Figure 37. Europe Nasal Vaccines Sales Share by Country (2017-2028)
Figure 38. Europe Nasal Vaccines Revenue Share by Country (2017-2028)
Figure 39. Germany Nasal Vaccines Revenue (2017-2028) & (US$ Million)
Figure 40. France Nasal Vaccines Revenue (2017-2028) & (US$ Million)
Figure 41. U.K. Nasal Vaccines Revenue (2017-2028) & (US$ Million)
Figure 42. Italy Nasal Vaccines Revenue (2017-2028) & (US$ Million)
Figure 43. Russia Nasal Vaccines Revenue (2017-2028) & (US$ Million)
Figure 44. Asia Pacific Nasal Vaccines Sales Market Share by Type (2017-2028)
Figure 45. Asia Pacific Nasal Vaccines Revenue Market Share by Type (2017-2028)
  • Global Atrial Appendage Occluder Market Research Report 2023
    Published: 27-Jan-2023        Price: US 2900 Onwards        Pages: 94
    Highlights The global Atrial Appendage Occluder market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Atrial Appendage Occluder is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 thro......
  • Global Artichoke Extract Market Research Report 2023
    Published: 27-Jan-2023        Price: US 2900 Onwards        Pages: 86
    Highlights The global Artichoke Extract market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Artichoke Extract is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029. ......
  • Global Arteriovenous Fistula Treatment Market Research Report 2023
    Published: 27-Jan-2023        Price: US 2900 Onwards        Pages: 89
    Highlights The global Arteriovenous Fistula Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. North American market for Arteriovenous Fistula Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 20......
  • Global Antithrombin Market Research Report 2023
    Published: 27-Jan-2023        Price: US 2900 Onwards        Pages: 82
    Highlights The global Antithrombin market was valued at US$ 537.5 million in 2022 and is anticipated to reach US$ 691.6 million by 2029, witnessing a CAGR of 4.3% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. North American market for Antithrombin is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029. ......
  • Global Anti-Infective Vaccines Market Research Report 2023
    Published: 27-Jan-2023        Price: US 2900 Onwards        Pages: 101
    Highlights The global Anti-Infective Vaccines market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Anti-Infective Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through ......
  • Global Alzheimer's Drugs Market Research Report 2023
    Published: 27-Jan-2023        Price: US 2900 Onwards        Pages: 91
    Highlights The global Alzheimer's Drugs market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Alzheimer's Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029. ......
  • Global Alternative Medicines and Therapy Market Research Report 2023
    Published: 27-Jan-2023        Price: US 2900 Onwards        Pages: 86
    Highlights The global Alternative Medicines and Therapy market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. North American market for Alternative Medicines and Therapy is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period o......
  • Global Advance Wound Dressing Market Research Report 2023
    Published: 27-Jan-2023        Price: US 2900 Onwards        Pages: 91
    Highlights The global Advance Wound Dressing market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Advance Wound Dressing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 20......
  • Global Acromegaly Treatment Market Research Report 2023
    Published: 27-Jan-2023        Price: US 2900 Onwards        Pages: 85
    Highlights The global Acromegaly Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. North American market for Acromegaly Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs